A global health leader is exploring how SRI’s robotic telemanipulation technology can enhance pharmaceutical manufacturing.
Cleanrooms are critical environments for pharmaceutical manufacturing, requiring strict adherence to contamination control standards. Traditional methods of managing these environments can be time-consuming, labor-intensive, and prone to human error. SRI’s XRGo system addresses these challenges by providing a remote, immersive interface that enables operators to control robotic systems within the clean room.
Pfizer, a global leader in health solutions, is exploring how the XRGo system might advance its efforts to innovate in its pharmaceutical cleanroom operations. With the integration of SRI’s advanced XRGo robotics technology, Pfizer aims to further enhance the efficiency, safety, and compliance of its manufacturing processes.
“Our work with Pfizer and others in the pharmaceutical industry demonstrates the power of technology to transform industries.” — Peter Marcotullio
“We are working with SRI to validate XRGo’s capabilities in our innovation lab, with the goal of understanding its potential impact on operational efficiency,” said Jean-Maxime Guay, Senior Manager, Manufacturing Intelligence at Pfizer. “Pfizer is always looking for ways to enhance the quality and consistency of our manufacturing processes, ultimately benefiting people worldwide.”
By leveraging augmented reality and virtual reality technologies, SRI’s XRGo system empowers operators to perform complex tasks with precision and efficiency, while further minimizing the risk of contamination. This innovative approach not only improves productivity but also ensures adherence to stringent regulatory requirements like the EU’s ANNEX 1. XRGo’s unique capabilities recently earned it a prestigious Robotics Application of the Year award from the International Society for Pharmaceutical Engineering.
“SRI is committed to developing innovative solutions that address real-world challenges,” said Peter Marcotullio, SRI’s Senior Vice President of Commercialization. “Our work with Pfizer and others in the pharmaceutical industry demonstrates the power of technology to transform industries.”
SRI’s XRGo robotics system is designed to seamlessly integrate with existing infrastructures, making it a flexible and cost-effective solution for pharmaceutical manufacturers. By leveraging SRI’s expertise in robotics and AI, the pharmaceutical industry can find new ways to streamline existing processes.
If you would like to learn more or schedule a demonstration of our robotics innovations, contact us today.
